Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models

被引：0
|
作者：
Dusek, Rachel [1 ]
Robillard, Liliane [1 ]
Harding, Thomas [1 ]
Simmons, Andrew [1 ]
Minh Nguyen [1 ]
机构：
[1] Clovis Oncol Inc, San Francisco, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P242
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Radiation enhances anti-tumor activity of immune checkpoint blockade in syngeneic tumor models
    Urs, Sumithra
    Meade, Mary Anne
    Guley, Kevin
    Krueger, Sarah
    Wong, Alden
    Wise, Scott
    Franklin, Maryland
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
    Liu, Xiaowei
    Feng, Yanlin
    Xu, Jie
    Shi, Ying
    Yang, Jiqiao
    Zhang, Rongjie
    Song, Jinen
    Bai, Xin
    Wu, Xi
    Bao, Yu
    Luo, Ya
    Li, Huifang
    Chai, Li
    Gong, Changyang
    Wang, Yan
    Chen, Bo
    Hu, Jianping
    Fu, Yan
    Luo, Yongzhang
    Zhang, Haiyuan
    Shi, Hubing
    JOURNAL OF CONTROLLED RELEASE, 2021, 332 : 194 - 209
  • [3] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [5] Enhancement of anti-PD-1 antitumor efficacy in syngeneic preclinical models by the angiogenesis inhibitor lucitanib
    Dusek, Rachel L.
    Robillard, Liliane
    Harding, Thomas C.
    Simmons, Andrew D.
    Minh Nguyen
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Anti-tumor Immunity and Improved Survival with Combination of Immune Checkpoint Blockade and Local Chemotherapy
    Green, J.
    Rudensky, A.
    Ariyan, C. E.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S113 - S113
  • [7] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
    Sparks, R.
    Rolland, S.
    Klinz, S.
    Meyer-Losic, F.
    Nakhle, J.
    Delille, R.
    de Boisferonc, M. Hillairet
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade (vol 332, pg 194, 2021)
    Liu, Xiaowei
    Feng, Yanlin
    Xu, Jie
    Shi, Ying
    Yang, Jiqiao
    Zhang, Rongjie
    Song, Jinen
    Bai, Xin
    Wu, Xi
    Bao, Yu
    Luo, Ya
    Li, Huifang
    Chai, Li
    Gong, Changyang
    Wang, Yan
    Chen, Bo
    Hu, Jianping
    Fu, Yan
    Luo, Yongzhang
    Zhang, Haiyuan
    Shi, Hubing
    JOURNAL OF CONTROLLED RELEASE, 2025, 377 : 397 - 398
  • [9] Corticosteroid premedication on anti-tumor effect of immune checkpoint blockade in murine hepatocellular carcinoma models
    Shen, Ying-Chun
    Chang, Nai-Wen
    Yeh, Ching-Ping
    Lin, Wan-Ying
    Wei, Ming-Feng
    Ou, Da-Liang
    Hsu, Chia-Lang
    Cheng, Ann-Lii
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [10] Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
    Zheng, Weiwei
    Qian, Cheng
    Tang, Yu
    Yang, Chunmei
    Zhou, Yueke
    Shen, Peiliang
    Chen, Wenxing
    Yu, Suyun
    Wei, Zhonghong
    Wang, Aiyun
    Lu, Yin
    Zhao, Yang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345